Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Q3 Earnings Season to Gather Pace This Week
03:08pm, Monday, 17'th Oct 2022 Zacks Investment Research
Q3 Earnings Season to Gather Pace This Week
Pre-Markets Up to Start a New Week
02:33pm, Monday, 17'th Oct 2022 Zacks Investment Research
The Dow is +350 points ahead of the open, the S&P is +50 and the Nasdaq is +160 points.
Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener
12:50pm, Monday, 17'th Oct 2022 Zacks Investment Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Is ALPS O'Shares U.S. Quality Dividend ETF (OUSA) a Strong ETF Right Now?
10:20am, Monday, 17'th Oct 2022 Zacks Investment Research
Smart Beta ETF report for OUSA
Penny Stocks & The Stock Market This Week: What To Watch Now
06:47pm, Sunday, 16'th Oct 2022 PennyStocks
Trading penny stocks right now? Here’s what to watch in the stock market this week October 17, 2022 to October 21, 2022.
The post Penny Stocks & The Stock Market This Week: What To Watch Now appeare
Netflix and Tesla stocks are not having a good year, but here comes a chance to turn it around
01:30pm, Sunday, 16'th Oct 2022 MarketWatch
Wall Street in the week ahead will turn to quarterly results from companies like streaming giant Netflix Inc. and electric-vehicle maker Tesla Inc.
How Warren Buffett Receives a Staggering 54% Yield From This Dividend Aristocrat
09:55am, Saturday, 15'th Oct 2022 The Motley Fool
The iconic investor's approach could work for anyone hoping to retire with significant dividend income.
Can Bank Stocks Maintain the Recent Momentum?
11:13pm, Friday, 14'th Oct 2022 Zacks Investment Research
The market liked what it saw in the quarterly releases from JPMorgan (JPM), Citigroup (C) and even Wells Fargo (WFC) on an otherwise down day for the indexes.
Johnson & Johnson Q3 Preview: Can the Earnings Streak Continue?
09:40pm, Friday, 14'th Oct 2022 Zacks Investment Research
JNJ has a stellar earnings track record, exceeding the Zacks Consensus EPS Estimate in each quarter dating all the way back to 2012.
Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again
04:10pm, Friday, 14'th Oct 2022 Zacks Investment Research
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Top Biotech Stocks to Buy Right Now
02:15pm, Friday, 14'th Oct 2022 The Motley Fool
Healthcare is a reliable sector of the economy for those looking to create wealth over the long haul.
J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector
05:01pm, Thursday, 13'th Oct 2022 Zacks Investment Research
J&J's (JNJ) Pharma segment is expected to have performed above the market. In the MedTech segment, sales in the second half are expected to have been better than the first.
Why the Bear Market May Not Be Over Anytime Soon
09:30am, Thursday, 13'th Oct 2022 The Motley Fool
Are investors better off waiting until next year to buy stocks?
Analyst Casts Doubts On Merus' Lung Candidate Safety Profile
06:19pm, Wednesday, 12'th Oct 2022 Benzinga
Earlier today, Merus N.V. (NASDAQ: MRUS) announced the publication of the abstract highlighting interim data from the ongoing phase 1/2 trial of the bispecific antibody MCLA-129 in advanced non-smal
What 7 Analyst Ratings Have To Say About Johnson & Johnson
05:07pm, Wednesday, 12'th Oct 2022 Benzinga
Over the past 3 months, 7 analysts have published their opinion on Johnson & Johnson (NYSE:JNJ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a
